glp-1 agonists and sglt2 inhibitors combination vs. to Treat the Heart, the Kidneys the Brain Combining glucagon-like peptide-1 receptor agonists
Description
As covered in an earlier analysis of CagriSemas Phase 3 data, the journey to that decision has not been without complexity
The knee injury and osteoarthritis outcome score (KOOS): from joint injury to osteoarthritis
The synergistic effect makes combination therapy attractive for patients requiring stronger glycemic control who haven't achieved targets on monotherapy
This is the story behind microdosing GLP-1 receptor agonists for autoimmune conditions
Introducing the Thyroid Gland as Another Victim of the Insulin Resistance Syndrome
Liu L, Omar B, Marchetti P, Ahren B
